TY - JOUR AU - Crawford, E. D. AU - Eisenberg, M. A. AU - McLeod, D. G. AU - Spaulding, J. T. AU - Benson, R. AU - Dorr, F. A. AU - Blumenstein, B. A. AU - Davis, M. A. AU - Goodman, P. J. PY - 1989 DA - 1989// TI - A controlled trial of leuprolide with and without flutamide in prostatic carcinoma JO - N Engl J Med VL - 321 UR - https://doi.org/10.1056/NEJM198908173210702 DO - 10.1056/NEJM198908173210702 ID - Crawford1989 ER - TY - JOUR AU - Heinlein, C. A. AU - Chang, C. PY - 2004 DA - 2004// TI - Androgen receptor in prostate cancer JO - Endocr Rev VL - 25 UR - https://doi.org/10.1210/er.2002-0032 DO - 10.1210/er.2002-0032 ID - Heinlein2004 ER - TY - JOUR AU - Taplin, M. E. AU - Balk, S. P. PY - 2004 DA - 2004// TI - Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence JO - J Cell Biochem VL - 91 UR - https://doi.org/10.1002/jcb.10653 DO - 10.1002/jcb.10653 ID - Taplin2004 ER - TY - JOUR AU - Edwards, J. AU - Krishna, N. S. AU - Grigor, K. M. AU - Bartlett, J. M. PY - 2003 DA - 2003// TI - Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer JO - Br J Cancer VL - 89 UR - https://doi.org/10.1038/sj.bjc.6601127 DO - 10.1038/sj.bjc.6601127 ID - Edwards2003 ER - TY - JOUR AU - Feldman, B. J. AU - Feldman, D. PY - 2001 DA - 2001// TI - The development of androgen-independent prostate cancer JO - Nat Rev Cancer VL - 1 UR - https://doi.org/10.1038/35094009 DO - 10.1038/35094009 ID - Feldman2001 ER - TY - JOUR AU - Attar, R. M. AU - Takimoto, C. H. AU - Gottardis, M. M. PY - 2009 DA - 2009// TI - Castration-resistant prostate cancer: locking up the molecular escape routes JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1171 DO - 10.1158/1078-0432.CCR-08-1171 ID - Attar2009 ER - TY - JOUR AU - Hsu, F. N. AU - Yang, M. S. AU - Lin, E. AU - Tseng, C. F. AU - Lin, H. PY - 2011 DA - 2011// TI - The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells JO - Am J Physiol Endocrinol Metab VL - 300 UR - https://doi.org/10.1152/ajpendo.00610.2010 DO - 10.1152/ajpendo.00610.2010 ID - Hsu2011 ER - TY - JOUR AU - Zhu, M. L. AU - Kyprianou, N. PY - 2008 DA - 2008// TI - Androgen receptor and growth factor signaling cross-talk in prostate cancer cells JO - Endocr Relat Cancer VL - 15 UR - https://doi.org/10.1677/ERC-08-0084 DO - 10.1677/ERC-08-0084 ID - Zhu2008 ER - TY - JOUR AU - Raj, G. V. AU - Barki-Harrington, L. AU - Kue, P. F. AU - Daaka, Y. PY - 2002 DA - 2002// TI - Guanosine phosphate binding protein coupled receptors in prostate cancer: a review JO - J Urol VL - 167 UR - https://doi.org/10.1016/S0022-5347(05)65345-1 DO - 10.1016/S0022-5347(05)65345-1 ID - Raj2002 ER - TY - JOUR AU - Thompson, T. C. AU - Kadmon, D. AU - Timme, T. L. AU - Merz, V. W. AU - Egawa, S. AU - Krebs, T. AU - Scardino, P. T. AU - Park, S. H. PY - 1991 DA - 1991// TI - Experimental oncogene induced prostate cancer JO - Cancer Surv VL - 11 ID - Thompson1991 ER - TY - JOUR AU - Berges, R. R. AU - Furuya, Y. AU - Remington, L. AU - English, H. F. AU - Jacks, T. AU - Isaacs, J. T. PY - 1993 DA - 1993// TI - Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation JO - Proc Natl Acad Sci USA VL - 90 UR - https://doi.org/10.1073/pnas.90.19.8910 DO - 10.1073/pnas.90.19.8910 ID - Berges1993 ER - TY - JOUR AU - Weidner, N. AU - Semple, J. P. AU - Welch, W. R. AU - Folkman, J. PY - 1991 DA - 1991// TI - Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma JO - N Engl J Med VL - 324 UR - https://doi.org/10.1056/NEJM199101033240101 DO - 10.1056/NEJM199101033240101 ID - Weidner1991 ER - TY - JOUR AU - Schröder, F. PY - 2008 DA - 2008// TI - Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms JO - Eur Urol VL - 53 UR - https://doi.org/10.1016/j.eururo.2008.01.049 DO - 10.1016/j.eururo.2008.01.049 ID - Schröder2008 ER - TY - JOUR AU - Isaacs, J. T. PY - 1999 DA - 1999// TI - The biology of hormone refractory prostate cancer. Why does it develop? JO - Urol Clin North Am VL - 26 UR - https://doi.org/10.1016/S0094-0143(05)70066-5 DO - 10.1016/S0094-0143(05)70066-5 ID - Isaacs1999 ER - TY - JOUR AU - Lyons, L. S. AU - Rao, S. AU - Balkan, W. AU - Faysal, J. AU - Maiorino, C. A. AU - Burnstein, K. L. PY - 2008 DA - 2008// TI - Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer JO - Mol Endocrinol VL - 22 UR - https://doi.org/10.1210/me.2007-0158 DO - 10.1210/me.2007-0158 ID - Lyons2008 ER - TY - JOUR AU - Lyons, L. S. AU - Burnstein, K. L. PY - 2006 DA - 2006// TI - Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity JO - Mol Endocrinol VL - 20 UR - https://doi.org/10.1210/me.2005-0346 DO - 10.1210/me.2005-0346 ID - Lyons2006 ER - TY - JOUR AU - Dong, Z. AU - Liu, Y. AU - Lu, S. AU - Wang, A. AU - Lee, K. AU - Wang, L. H. AU - Revelo, M. AU - Lu, S. PY - 2006 DA - 2006// TI - Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer JO - Mol Endocrinol VL - 20 UR - https://doi.org/10.1210/me.2006-0048 DO - 10.1210/me.2006-0048 ID - Dong2006 ER - TY - JOUR AU - Bustelo, X. R. PY - 2000 DA - 2000// TI - Regulatory and signaling properties of the Vav family JO - Mol Cell Biol VL - 20 UR - https://doi.org/10.1128/MCB.20.5.1461-1477.2000 DO - 10.1128/MCB.20.5.1461-1477.2000 ID - Bustelo2000 ER - TY - JOUR AU - Bustelo, X. R. PY - 2001 DA - 2001// TI - Vav proteins, adaptors and cell signaling JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204780 DO - 10.1038/sj.onc.1204780 ID - Bustelo2001 ER - TY - JOUR AU - Hornstein, I. AU - Alcover, A. AU - Katzav, S. PY - 2004 DA - 2004// TI - Vav proteins, masters of the world of cytoskeleton organization JO - Cell Signal VL - 16 UR - https://doi.org/10.1016/S0898-6568(03)00110-4 DO - 10.1016/S0898-6568(03)00110-4 ID - Hornstein2004 ER - TY - JOUR AU - Zugaza, J. L. AU - López-Lago, M. A. AU - Caloca, M. J. AU - Dosil, M. AU - Movilla, N. AU - Bustelo, X. R. PY - 2002 DA - 2002// TI - Structural determinants for the biological activity of Vav proteins JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M208039200 DO - 10.1074/jbc.M208039200 ID - Zugaza2002 ER - TY - JOUR AU - Katzav, S. AU - Martin-Zanca, D. AU - Barbacid, M. PY - 1989 DA - 1989// TI - vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells JO - EMBO J VL - 8 ID - Katzav1989 ER - TY - JOUR AU - Zeng, L. AU - Sachdev, P. AU - Yan, L. AU - Chan, J. L. AU - Trenkle, T. AU - McClelland, M. AU - Welsh, J. AU - Wang, L. H. PY - 2000 DA - 2000// TI - Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation JO - Mol Cell Biol VL - 20 UR - https://doi.org/10.1128/MCB.20.24.9212-9224.2000 DO - 10.1128/MCB.20.24.9212-9224.2000 ID - Zeng2000 ER - TY - CHAP AU - Hirai, K. AU - Nomura, T. AU - Yamasaki, M. AU - Inoue, T. AU - Narimatsu, T. AU - Nakada, C. AU - Tsukamoto, Y. AU - Matsuura, K. AU - Sato, F. AU - Moriyama, M. AU - Mimata, H. PY - 2013 DA - 2013// TI - The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia BT - Urol Oncol ID - Hirai2013 ER - TY - CHAP AU - Yamasaki, M. AU - Nomura, T. AU - Sato, F. AU - Mimata, H. PY - 2012 DA - 2012// TI - Chronic hypoxia induces androgen-independent and invasive behavior in LNCaP human prostate cancer cells BT - Urol Oncol ID - Yamasaki2012 ER - TY - JOUR AU - Petrylak, D. P. AU - Tangen, C. M. AU - Hussain, M. H. AU - Lara, P. N. AU - Jones, A. AU - Taplin, M. E. AU - Burch, P. A. AU - Berry, D. AU - Moinpour, C. AU - Kohli, M. AU - Benson, M. C. AU - Small, E. J. AU - Raghavan, D. AU - Crawford, E. D. PY - 2004 DA - 2004// TI - Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa041318 DO - 10.1056/NEJMoa041318 ID - Petrylak2004 ER - TY - JOUR AU - Tannock, I. F. AU - de Wit, R. AU - Berry, W. R. AU - Horti, J. AU - Pluzanska, A. AU - Chi, K. N. AU - Oudard, S. AU - Théodore, C. AU - James, N. D. AU - Turesson, I. AU - Rosenthal, M. A. AU - Eisenberger, M. A. PY - 2004 DA - 2004// TI - Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa040720 DO - 10.1056/NEJMoa040720 ID - Tannock2004 ER - TY - JOUR AU - Montero, A. AU - Fossella, F. AU - Hortobagyi, G. AU - Valero, V. PY - 2005 DA - 2005// TI - Docetaxel for treatment of solid tumours: a systematic review of clinical data JO - Lancet Oncol VL - 6 UR - https://doi.org/10.1016/S1470-2045(05)70094-2 DO - 10.1016/S1470-2045(05)70094-2 ID - Montero2005 ER - TY - JOUR AU - Mabjeesh, N. J. AU - Willard, M. T. AU - Frederickson, C. E. AU - Zhong, H. AU - Simons, J. W. PY - 2003 DA - 2003// TI - Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3′-kinase/protein kinase B in prostate cancer cells JO - Clin Cancer Res VL - 9 ID - Mabjeesh2003 ER - TY - JOUR AU - Stewart, R. J. AU - Panigrahy, D. AU - Flynn, E. AU - Folkman, J. PY - 2001 DA - 2001// TI - Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts JO - J Urol VL - 165 UR - https://doi.org/10.1097/00005392-200102000-00095 DO - 10.1097/00005392-200102000-00095 ID - Stewart2001 ER - TY - JOUR AU - Isaacs, J. S. AU - Jung, Y. J. AU - Mimnaugh, E. G. AU - Martinez, A. AU - Cuttitta, F. AU - Neckers, L. M. PY - 2002 DA - 2002// TI - Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M204733200 DO - 10.1074/jbc.M204733200 ID - Isaacs2002 ER - TY - JOUR AU - Lisanti, M. P. AU - Martinez-Outschoorn, U. E. AU - Chiavarina, B. AU - Pavlides, S. AU - Whitaker-Menezes, D. AU - Tsirigos, A. AU - Witkiewicz, A. AU - Lin, Z. AU - Balliet, R. AU - Howell, A. AU - Sotgia, F. PY - 2010 DA - 2010// TI - Understanding the “lethal” drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment JO - Cancer Biol Ther VL - 10 UR - https://doi.org/10.4161/cbt.10.6.13370 DO - 10.4161/cbt.10.6.13370 ID - Lisanti2010 ER - TY - JOUR AU - Suzuki, Y. AU - Kondo, Y. AU - Hara, S. AU - Kimata, R. AU - Nishimura, T. PY - 2010 DA - 2010// TI - Effect of the hsp90 inhibitor geldanamycin on androgen response of prostate cancer under hypoxic conditions JO - Int J Urol VL - 17 UR - https://doi.org/10.1111/j.1442-2042.2010.02450.x DO - 10.1111/j.1442-2042.2010.02450.x ID - Suzuki2010 ER - TY - JOUR AU - Butterworth, K. T. AU - McCarthy, H. O. AU - Devlin, A. AU - Ming, L. AU - Robson, T. AU - McKeown, S. R. AU - Worthington, J. PY - 2008 DA - 2008// TI - Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype JO - Int J Cancer VL - 123 UR - https://doi.org/10.1002/ijc.23418 DO - 10.1002/ijc.23418 ID - Butterworth2008 ER - TY - JOUR AU - Datta, S. R. AU - Dudek, H. AU - Tao, X. AU - Masters, S. AU - Fu, H. AU - Gotoh, Y. AU - Greenberg, M. E. PY - 1997 DA - 1997// TI - Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery JO - Cell VL - 91 UR - https://doi.org/10.1016/S0092-8674(00)80405-5 DO - 10.1016/S0092-8674(00)80405-5 ID - Datta1997 ER - TY - JOUR AU - Scheid, M. P. AU - Schubert, K. M. AU - Duronio, V. PY - 1999 DA - 1999// TI - Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.43.31108 DO - 10.1074/jbc.274.43.31108 ID - Scheid1999 ER - TY - JOUR AU - Gao, H. AU - Ouyang, X. AU - Banach-Petrosky, W. A. AU - Gerald, W. L. AU - Shen, M. M. AU - Abate-Shen, C. PY - 2006 DA - 2006// TI - Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer JO - Proc Natl Acad Sci USA VL - 103 UR - https://doi.org/10.1073/pnas.0606836103 DO - 10.1073/pnas.0606836103 ID - Gao2006 ER - TY - JOUR AU - Liu, Y. AU - Mo, J. Q. AU - Hu, Q. AU - Boivin, G. AU - Levin, L. AU - Lu, S. AU - Yang, D. AU - Dong, Z. AU - Lu, S. PY - 2008 DA - 2008// TI - Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0645 DO - 10.1158/0008-5472.CAN-08-0645 ID - Liu2008 ER - TY - JOUR AU - Morgan, T. M. AU - Koreckij, T. D. AU - Corey, E. PY - 2009 DA - 2009// TI - Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway JO - Curr Cancer Drug Targets VL - 9 UR - https://doi.org/10.2174/156800909787580999 DO - 10.2174/156800909787580999 ID - Morgan2009 ER - TY - JOUR AU - Deng, X. AU - Xiao, L. AU - Lang, W. AU - Gao, F. AU - Ruvolo, P. AU - May, W. S. PY - 2001 DA - 2001// TI - Novel role for JNK as a stress-activated Bcl2 kinase JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M100279200 DO - 10.1074/jbc.M100279200 ID - Deng2001 ER - TY - JOUR AU - Bhakar, A. L. AU - Howell, J. L. AU - Paul, C. E. AU - Salehi, A. H. AU - Becker, E. B. AU - Said, F. AU - Bonni, A. AU - Barker, P. A. PY - 2003 DA - 2003// TI - Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad JO - J Neurosci VL - 23 ID - Bhakar2003 ER - TY - JOUR AU - Sunayama, J. AU - Tsuruta, F. AU - Masuyama, N. AU - Gotoh, Y. PY - 2005 DA - 2005// TI - JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3 JO - J Cell Biol VL - 170 UR - https://doi.org/10.1083/jcb.200409117 DO - 10.1083/jcb.200409117 ID - Sunayama2005 ER - TY - JOUR AU - Yamamoto, K. AU - Ichijo, H. AU - Korsmeyer, S. J. PY - 1999 DA - 1999// TI - BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M JO - Mol Cell Biol VL - 19 UR - https://doi.org/10.1128/MCB.19.12.8469 DO - 10.1128/MCB.19.12.8469 ID - Yamamoto1999 ER -